Value of FDG PET/CT in patient management and outcome of skeletal and soft tissue sarcomas

Sara Sheikhbahaei; Charles Marcus; Nima Hafezi-Nejad; Mehdi Taghipour; Rathan M. Subramaniam

doi:10.1016/j.cpet.2015.03.003

Value of FDG PET/CT in patient management and outcome of skeletal and soft tissue sarcomas

Sara Sheikhbahaei, Charles Marcus, Nima Hafezi-Nejad, Mehdi Taghipour, Rathan M. Subramaniam

Research output: Contribution to journal › Review article › peer-review

29 Scopus citations

Abstract

Fluorodeoxyglucose (FDG)-PET/computed tomography (CT) has been increasingly used in bone and soft tissue sarcomas and provides advantages in the initial tumor staging, tumor grading, therapy assessment, and recurrence detection. FDG-PET/CT metabolic parameters are reliable predictors of survival in sarcomas and could be implemented in risk stratification models along with other prognostic factors in these patients.

Original language	English (US)
Pages (from-to)	375-393
Number of pages	19
Journal	PET Clinics
Volume	10
Issue number	3
DOIs	https://doi.org/10.1016/j.cpet.2015.03.003
State	Published - Jul 1 2015

Keywords

Computed tomography
Fluorodeoxyglucose
PET
Patient management
Skeletal sarcoma
Soft tissue sarcoma

ASJC Scopus subject areas

Radiation
Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.cpet.2015.03.003

Cite this

@article{4cd15e4498e14ce4b21f1539164f062b,

title = "Value of FDG PET/CT in patient management and outcome of skeletal and soft tissue sarcomas",

abstract = "Fluorodeoxyglucose (FDG)-PET/computed tomography (CT) has been increasingly used in bone and soft tissue sarcomas and provides advantages in the initial tumor staging, tumor grading, therapy assessment, and recurrence detection. FDG-PET/CT metabolic parameters are reliable predictors of survival in sarcomas and could be implemented in risk stratification models along with other prognostic factors in these patients.",

keywords = "Computed tomography, Fluorodeoxyglucose, PET, Patient management, Skeletal sarcoma, Soft tissue sarcoma",

author = "Sara Sheikhbahaei and Charles Marcus and Nima Hafezi-Nejad and Mehdi Taghipour and Subramaniam, {Rathan M.}",

note = "Publisher Copyright: {\textcopyright} 2015 Elsevier Inc.",

year = "2015",

month = jul,

day = "1",

doi = "10.1016/j.cpet.2015.03.003",

language = "English (US)",

volume = "10",

pages = "375--393",

journal = "PET Clinics",

issn = "1556-8598",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Value of FDG PET/CT in patient management and outcome of skeletal and soft tissue sarcomas

AU - Sheikhbahaei, Sara

AU - Marcus, Charles

AU - Hafezi-Nejad, Nima

AU - Taghipour, Mehdi

AU - Subramaniam, Rathan M.

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Fluorodeoxyglucose (FDG)-PET/computed tomography (CT) has been increasingly used in bone and soft tissue sarcomas and provides advantages in the initial tumor staging, tumor grading, therapy assessment, and recurrence detection. FDG-PET/CT metabolic parameters are reliable predictors of survival in sarcomas and could be implemented in risk stratification models along with other prognostic factors in these patients.

AB - Fluorodeoxyglucose (FDG)-PET/computed tomography (CT) has been increasingly used in bone and soft tissue sarcomas and provides advantages in the initial tumor staging, tumor grading, therapy assessment, and recurrence detection. FDG-PET/CT metabolic parameters are reliable predictors of survival in sarcomas and could be implemented in risk stratification models along with other prognostic factors in these patients.

KW - Computed tomography

KW - Fluorodeoxyglucose

KW - PET

KW - Patient management

KW - Skeletal sarcoma

KW - Soft tissue sarcoma

UR - http://www.scopus.com/inward/record.url?scp=84931955662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931955662&partnerID=8YFLogxK

U2 - 10.1016/j.cpet.2015.03.003

DO - 10.1016/j.cpet.2015.03.003

M3 - Review article

C2 - 26099673

AN - SCOPUS:84931955662

SN - 1556-8598

VL - 10

SP - 375

EP - 393

JO - PET Clinics

JF - PET Clinics

IS - 3

ER -

Value of FDG PET/CT in patient management and outcome of skeletal and soft tissue sarcomas

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this